GG
Gofen & Glossberg Portfolio holdings
AUM
$3.89B
This Quarter Return
+3.93%
1 Year Return
-11.97%
3 Year Return
+36.42%
5 Year Return
+73.97%
10 Year Return
–
AUM
$2.7B
AUM Growth
+$2.7B
(+2.4%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
23.88%
Holding
495
New
21
Increased
128
Reduced
182
Closed
21
Top Buys
| 1 |
DuPont de Nemours
DD
|
$21.6M |
| 2 |
Amazon
AMZN
|
$6.18M |
| 3 |
Johnson Controls International
JCI
|
$2.25M |
| 4 |
Brighthouse Financial
BHF
|
$1.16M |
| 5 |
Becton Dickinson
BDX
|
$1.14M |
Top Sells
| 1 |
DD
Du Pont De Nemours E I
DD
|
$20.2M |
| 2 |
Boeing
BA
|
$2.44M |
| 3 |
TIF
Tiffany & Co.
TIF
|
$2.04M |
| 4 |
IBM
IBM
|
$2.04M |
| 5 |
Target
TGT
|
$1.69M |
Sector Composition
| 1 | Healthcare | 16.01% |
| 2 | Financials | 13.42% |
| 3 | Industrials | 11.95% |
| 4 | Technology | 11.34% |
| 5 | Consumer Staples | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Meta Platforms (Facebook)
META
$1.86T
| $25.4M | 0.94% | 148,490 -970 | -0.6% | -$166K |
|
27
Abbott
ABT
$231B
| $25.1M | 0.93% | 469,877 -5,022 | -1% | -$268K |
|
|
28
DuPont de Nemours
DD
$32.2B
| $24.7M | 0.92% | 356,308 +311,961 | +703% | +$21.6M |
|
29
Merck
MRK
$210B
| $24M | 0.89% | 374,339 +611 | +0.2% | +$39.1K |
|
30
3M
MMM
$82.8B
| $23.7M | 0.88% | 113,098 -313 | -0.3% | -$65.7K |
|
31
Coca-Cola
KO
$297B
| $23.3M | 0.87% | 518,555 -19,121 | -4% | -$861K |
|
32
Kraft Heinz
KHC
$33.1B
| $22.8M | 0.85% | 293,844 -1,483 | -0.5% | -$115K |
|
33
Mastercard
MA
$538B
| $21.9M | 0.81% | 155,442 -1,581 | -1% | -$223K |
|
34
Novartis
NVS
$245B
| $21.7M | 0.81% | 253,090 -5,678 | -2% | -$487K |
|
35
Berkshire Hathaway Class B
BRK.B
$1.09T
| $21.6M | 0.8% | 117,627 +175 | +0.1% | +$32.1K |
|
36
Mondelez International
MDLZ
$79.5B
| $21.5M | 0.8% | 528,363 +2,183 | +0.4% | +$88.8K |
|
37
Verizon
VZ
$186B
| $20.9M | 0.78% | 422,196 -7,548 | -2% | -$374K |
|
|
UN
38
DELISTED
Unilever NV New York Registry Shares
UN
| $20M | 0.74% | 338,488 -2,724 | -0.8% | -$161K |
|
39
Gilead Sciences
GILD
$140B
| $19.7M | 0.73% | 243,048 -15,748 | -6% | -$1.28M |
|
40
Citigroup
C
$178B
| $19.7M | 0.73% | 270,307 +1,465 | +0.5% | +$107K |
|
41
Alphabet (Google) Class A
GOOGL
$2.57T
| $19.4M | 0.72% | 19,972 -447 | -2% | -$435K |
|
42
MetLife
MET
$54.1B
| $19.2M | 0.71% | 370,440 -15,087 | -4% | -$784K |
|
43
Wells Fargo
WFC
$263B
| $19M | 0.7% | 343,913 -27,159 | -7% | -$1.5M |
|
44
Zoetis
ZTS
$69.3B
| $18.3M | 0.68% | 287,354 -1,995 | -0.7% | -$127K |
|
|
AGN
45
DELISTED
Allergan plc
AGN
| $18M | 0.67% | 87,764 +4,729 | +6% | +$969K |
|
46
Nike
NKE
$114B
| $17.7M | 0.66% | 341,174 -8,352 | -2% | -$433K |
|
47
Broadcom
AVGO
$1.4T
| $17.6M | 0.65% | 72,608 +1,104 | +2% | +$268K |
|
48
Philip Morris
PM
$260B
| $17.5M | 0.65% | 158,058 -172 | -0.1% | -$19.1K |
|
49
Danaher
DHR
$147B
| $17.4M | 0.65% | 203,071 +4,383 | +2% | +$376K |
|
50
AbbVie
ABBV
$372B
| $17.3M | 0.64% | 195,098 -8,735 | -4% | -$776K |
|